Literature DB >> 7433630

The natural history of diabetic autonomic neuropathy.

D J Ewing, I W Campbell, B F Clarke.   

Abstract

Seventy-three diabetics (62 males and 11 females) who complained of symptoms suggestive of autonomic neuropathy were followed prospectively for up to five years. Thirty patients presented with impotence alone, while the other 43 presented with one or more of the following: postural hypotension, intermittent diarrhoea, hypoglycaemic unawareness, sweating abnormalities and gastric fullness. Most subjects with impotence alone had normal autonomic function tests (responses to the Valsalva manoeuvre and sustained handgrip) whereas the majority with other symptoms had abnormal tests. Twenty-six subjects (20 males and six females) died during the follow-up period. Of the 33 with initially normal autonomic function tests, five (15 per cent) died, whereas of the 40 with initially abnormal tests, 21 (53 per cent) died. Diabetics with symptoms of autonomic neuropathy and abnormal autonomic function tests, had a calculated mortality rate after two-and-a-half years of 44 per cent and after five years of 56 per cent. Half the deaths in those with abnormal tests were from renal failure, and the remainder were either sudden and unexpected, or from other causes which may have been associated with the autonomic neuropathy. Autonomic function testing repeated during the follow-up period showed that some normal tests later became abnormal, but once tests were abnormal, they usually remained abnormal. A number of subjects with impotence alone developed other features of autonomic neuropathy and abnormal tests during the follow up period. Symptoms of autonomic neuropathy, particularly postural hypotension, gastric symptoms and hypoglycaemic unawareness, together with abnormal autonomic function tests, carry a very poor prognosis. Diarrhoea and importence, on their own, cannot be relied on as symptoms of autonomic neuropathy. Autonomic function testing using simple cardiovascular reflexes give a good guide to the prognosis of diabetic autonomic neuropathy.

Entities:  

Mesh:

Year:  1980        PMID: 7433630

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


  147 in total

Review 1.  MIBG imaging.

Authors:  Amar D Patel; Ami E Iskandrian
Journal:  J Nucl Cardiol       Date:  2002 Jan-Feb       Impact factor: 5.952

2.  The relationship between heart rate recovery and heart rate variability in coronary artery disease.

Authors:  Harun Evrengul; Halil Tanriverdi; Sedat Kose; Basri Amasyali; Ayhan Kilic; Turgay Celik; Hasan Turhan
Journal:  Ann Noninvasive Electrocardiol       Date:  2006-04       Impact factor: 1.468

3.  Microalbuminuria.

Authors:  P H Winocour
Journal:  BMJ       Date:  1992-05-09

4.  Diabetic autonomic neuropathy.

Authors:  R W Bilous
Journal:  BMJ       Date:  1990-09-22

5.  Aerobic training restores arterial baroreflex sensitivity in older adults with type 2 diabetes, hypertension, and hypercholesterolemia.

Authors:  Kenneth M Madden; Chris Lockhart; Tiffany F Potter; Darcye Cuff
Journal:  Clin J Sport Med       Date:  2010-07       Impact factor: 3.638

6.  Elevated angiotensin II in rat nodose ganglia primes diabetes-blunted arterial baroreflex sensitivity: involvement of NADPH oxidase-derived superoxide.

Authors:  Yu-Long Li
Journal:  J Diabetes Metab       Date:  2011-09-08

Review 7.  Autonomic dysfunction in chronic liver disease.

Authors:  M T Hendrickse; D R Triger
Journal:  Clin Auton Res       Date:  1993-08       Impact factor: 4.435

8.  Respiratory responses of diabetics to hypoxia, hypercapnia, and exercise.

Authors:  J G Williams; A I Morris; R C Hayter; C M Ogilvie
Journal:  Thorax       Date:  1984-07       Impact factor: 9.139

Review 9.  Neurologic complications of diabetes.

Authors:  Gerald A Charnogursky; Nicholas V Emanuele; Mary Ann Emanuele
Journal:  Curr Neurol Neurosci Rep       Date:  2014-07       Impact factor: 5.081

10.  Autonomic neuropathy in African diabetic patients.

Authors:  P S Tuch; G V Gill; K R Huddle
Journal:  Postgrad Med J       Date:  1994-03       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.